uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Targeting against epidermal growth factor receptors: Cellular processing of astatinated EGF after binding to cultured carcinoma cells
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Oncology, Radiology and Clinical Immunology, Biomedical Radiation Sciences.ORCID iD: 0000-0001-6120-2683
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Oncology, Radiology and Clinical Immunology, Biomedical Radiation Sciences.
Nuclear Physics Institute, Rez, Czech Republic.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Oncology, Radiology and Clinical Immunology, Biomedical Radiation Sciences.
Show others and affiliations
2004 (English)In: Anticancer Research, ISSN 0250-7005, Vol. 24, no 6, 4035-4042 p.Article in journal (Refereed) Published
Abstract [en]

BACKGROUND:

The alpha-emitting nuclide 211At is of great interest for radionuclide therapy when coupled to a tumor-targeting biomolecule, e.g. epidermal growth factor (EGF) the receptors of which are overexpressed in many malignancies. However, almost no information concerning the cellular processing of astatinated targeting agents is available.

MATERIALS AND METHODS:

We indirectly astatinated EGF ([211At]-benzoate-EGF) and studied its cellular processing in A-431 carcinoma cells in comparison with data concerning [125I]-benzoate-EGF.

RESULTS:

The biological half-life of astatine (3.5 h) was longer than the half-life of the iodine label (1.5 h). The increase of the half-life was due to longer retention of the internalised astatine radioactivity. The maximum accumulation for the astatine label occurred later (4-6h) than that for the iodine label (2-4h), indicating a slower excretion of astatine that was confirmed in experiment with 211At/1251-benzoate-EGF.

CONCLUSION:

The long retention of astatine might be advantageous for radionuclide therapy.

Place, publisher, year, edition, pages
2004. Vol. 24, no 6, 4035-4042 p.
Keyword [en]
Astatine/chemistry/metabolism/*pharmacokinetics, Carcinoma/*metabolism/radiotherapy, Cell Line; Tumor, Cell Membrane/metabolism, Epidermal Growth Factor/metabolism/*pharmacokinetics, Epithelioid Cells/metabolism/pathology, Half-Life, Humans, Iodobenzoates/metabolism/pharmacokinetics, Radiopharmaceuticals/metabolism/*pharmacokinetics, Receptor; Epidermal Growth Factor/*metabolism
National Category
Radiology, Nuclear Medicine and Medical Imaging
Identifiers
URN: urn:nbn:se:uu:diva-72882PubMedID: 15736449OAI: oai:DiVA.org:uu-72882DiVA: diva2:100793
Available from: 2007-03-09 Created: 2007-03-09 Last updated: 2015-03-24Bibliographically approved

Open Access in DiVA

No full text

Other links

PubMedhttp://ar.iiarjournals.org/content/24/6/4035.long

Authority records BETA

Orlova, AnnaSjöström, AnnaLundqvist, HansCarlsson, JorgenTolmachev, Vladimir

Search in DiVA

By author/editor
Orlova, AnnaSjöström, AnnaLundqvist, HansCarlsson, JorgenTolmachev, Vladimir
By organisation
Biomedical Radiation Sciences
In the same journal
Anticancer Research
Radiology, Nuclear Medicine and Medical Imaging

Search outside of DiVA

GoogleGoogle Scholar

pubmed
urn-nbn

Altmetric score

pubmed
urn-nbn
Total: 816 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf